Nomura Holdings
TEVA icon

Nomura Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Nomura Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7M Sell
555,000
-599,100
-52% -$19.3M 0.04% 294
2025
Q4 		$36M Buy
1,154,100
+1,023,900
+786% +$25.2M 0.05% 202
2025
Q3 		$2.63M Sell
130,200
-5,239,600
-98% -$92M ﹤0.01% 1037
2025
Q2 		$90M Buy
+5,369,800
New +$86.7M 0.19% 79
2025
Q1 		– Sell
-1,961,500
Closed -$43.2M – 2360
2024
Q4 		$43.2M Buy
+1,961,500
New +$35.7M 0.06% 180
2023
Q4 		– Sell
-2,727,500
Closed -$27.8M – 1970
2023
Q3 		$27.8M Buy
+2,727,500
New +$25.4M 0.08% 172
2022
Q4 		– Sell
-5,000
Closed -$40K – 1708
2022
Q3 		$40K Hold
5,000
– – ﹤0.01% 1398
2022
Q2 		$40K Hold
5,000
– – ﹤0.01% 1515
2022
Q1 		$47K Buy
+5,000
New +$41.7K ﹤0.01% 1765
2021
Q1 		– Sell
-100,000
Closed -$960K – 2271
2020
Q4 		$960K Buy
+100,000
New +$958K ﹤0.01% 1051
2018
Q3 		– Sell
-27,000
Closed -$512K – 1499
2018
Q2 		$512K Buy
+27,000
New +$551K ﹤0.01% 996
2017
Q4 		– Sell
-340,000
Closed -$5.98M – 1673
2017
Q3 		$5.98M Buy
340,000
+40,000
+13% +$900K 0.01% 498
2017
Q2 		$9.96M Hold
300,000
– – 0.02% 372
2017
Q1 		$9.63M Sell
300,000
-371,700
-55% -$12.7M 0.03% 315
2016
Q4 		$24.3M Sell
671,700
-1,560,600
-70% -$62.3M 0.06% 192
2016
Q3 		$103M Buy
2,232,300
+982,300
+79% +$51.3M 0.29% 56
2016
Q2 		$62.8M Buy
+1,250,000
New +$66.5M 0.21% 54
2015
Q3 		– Sell
-1,505,000
Closed -$76M – 1950
2015
Q2 		$76M Buy
+1,505,000
New +$92.8M 0.21% 55
2015
Q1 		– Sell
-2,706,300
Closed -$137M – 2248
2014
Q4 		$137M Buy
2,706,300
+236,300
+10% +$13.2M 0.37% 39
2014
Q3 		$125M Buy
2,470,000
+320,000
+15% +$17M 0.34% 56
2014
Q2 		$113M Sell
2,150,000
-274,000
-11% -$14M 0.03% 80
2014
Q1 		$127M Buy
+2,424,000
New +$112M 0.04% 65

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's TEVA Position: Q1 2026 in Review

Nomura Holdings opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 2,338,602 shares worth $70.4M. The stake represents 0.19% of the portfolio and ranks #85 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in TEVA as recently as Q3 2025.

Nomura Holdings first reported a position in TEVA in Q2 2013 and has held it in 42 quarters since. The position peaked at $75.9M in Q3 2014. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Nomura Holdings held 2,338,602 shares of Teva Pharmaceuticals worth $70.4M as of Q1 2026.
  • Teva Pharmaceuticals was a new Nomura Holdings position in Q1 2026.
  • Teva Pharmaceuticals made up 0.19% of Nomura Holdings's portfolio in Q1 2026, its #85 holding.
  • Nomura Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
  • Nomura Holdings's Teva Pharmaceuticals position peaked at $75.9M in Q3 2014.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.